AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Thymoglobulin market forecast points to faster growth through 2035
AGP
The Business Research Company says the global Thymoglobulin market is set to expand through 2035, driven by more organ transplants, rising autoimmune disease cases and broader use of antibody-based immunosuppressive therapies.
Tecartus market forecast points to growth through 2035
AGP
The Business Research Company says the Tecartus market is poised for continued expansion through 2035, driven by rising hematologic cancer cases, broader use of personalized medicine and more investment in CAR-T infrastructure.
Tepezza market forecast points to growth through 2035
AGP
The Business Research Company says the Tepezza market is expanding as thyroid eye disease diagnoses rise, infusion access broadens and interest grows in targeted autoimmune therapies.
Air traffic flow management market forecast to hit $49.73 billion by 2030
AGP
The global air traffic flow and capacity management market is projected to grow from $30.16 billion in 2026 to $49.73 billion by 2030, driven by rising passenger traffic, airport congestion and digital air traffic tools.
Survanta market forecast points to growth through 2030
AGP
The Survanta market is expanding as premature births rise and neonatal care improves, according to a new forecast from The Business Research Company.
Strimvelis market forecast points to growth through 2026
AGP
The Strimvelis gene therapy market is expected to expand through 2026 as rare disease diagnoses rise, healthcare spending increases and personalized medicine gains ground.
Ruconest market forecast points to faster growth through 2035
AGP
The Business Research Company says the Ruconest market is set to expand through 2035 as hereditary angioedema diagnosis rises, home infusion grows and rare-disease investment increases.
Repatha market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the Repatha market is set to expand through 2035, driven by rising cardiovascular disease, high cholesterol and obesity rates.
Chemotherapy-induced anemia market forecast to hit $4.13 billion by 2030
AGP
The chemotherapy-induced anemia market is projected to grow from $2.81 billion in 2025 to $4.13 billion by 2030, driven by more intensive cancer treatment, higher anemia rates and wider use of supportive care.
Rebyota market forecast points to growth through 2026
AGP
The Business Research Company says the Rebyota market is expected to expand as recurrent C. difficile infections, antibiotic use and microbiome research drive demand for microbiota-based therapies.
Rebif market forecast sees MS demand, aging populations drive growth
AGP
The Business Research Company says the global Rebif market is set to expand through 2035 as multiple sclerosis diagnoses rise, older populations grow and at-home injectable treatment demand increases.
Skyrizi market forecast improves on rising global demand
AGP
The Business Research Company says the global Skyrizi market is set for stronger growth through 2035 as autoimmune diagnoses rise, biologic use expands and demand increases across dermatology and gastroenterology.
Saphnelo market forecast points to steady growth through 2035
AGP
The Business Research Company says the Saphnelo market is set for long-term expansion as lupus diagnosis rates rise, biologic therapies advance and healthcare access improves.
Serostim market forecast points to growth through 2035
AGP
The Business Research Company says the Serostim market is set to expand through 2035, driven by rising HIV/AIDS diagnoses, broader chronic disease burden and growing demand for therapies that address wasting and loss of lean mass.
Spherusol market forecast points to growth as valley fever cases rise
AGP
The Business Research Company says the global Spherusol market is set for continued expansion through 2035, driven by rising coccidioidomycosis cases, stronger public health screening and broader use of diagnostic skin tests.
Spevigo market forecast points to steady growth through 2035
AGP
The Business Research Company says the global Spevigo market is positioned for steady expansion as rare-skin-disease awareness, biologics research and diagnosis of generalized pustular psoriasis improve.
Rylaze market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the Rylaze market is set to expand through 2035 as oncology biologics spending rises, personalized medicine gains ground, and leukemia treatment shifts toward recombinant enzymes.
Prolastin and Prolastin-C market forecast points to steady growth through 2026
AGP
The Business Research Company says the Prolastin and Prolastin-C market is expanding on stronger alpha-1 antitrypsin deficiency diagnosis, rising respiratory disease burden and more R&D investment.
Prolastin-C market forecast points to growth through 2030
AGP
The Prolastin-C market is projected to expand through 2030 as research spending rises, respiratory disease burden persists and hospitals keep using specialized immunotherapy approaches.
Provenge market forecast improves as demand rises
AGP
The Business Research Company says the Provenge market is set to expand as prostate cancer cases rise, clinical trials increase and healthcare spending grows.
Sign up for:
Market Forecast Analysis
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.